Next generation of multispecific antibody engineering.

Area of Science:

• Biotechnology
• Protein Engineering
• Immunotherapy

Background:

• Multispecific antibodies offer advanced therapeutic capabilities beyond traditional monoclonal antibodies or cytokines.
• Their development faces challenges, necessitating novel approaches and workflows.
• Understanding the assembly of protein building blocks into non-native quaternary structures is crucial.

Purpose of the Study:

• To propose a new workflow for the development of multispecific antibodies.
• To investigate the molecular basis governing the assembly of protein building blocks.
• To establish a predictive framework for designing next-generation therapeutic biologics.

Main Methods:

• Review of current state-of-the-art in therapeutic biologics.
• Analysis of protein building blocks and tools for molecular assembly.
• Exploration of quaternary structure formation in engineered proteins.

Main Results:

• Identification of key molecular principles for successful protein assembly.
• Conceptualization of a "playbook" for designing multispecific molecules.
• Highlighting the need for controlled and predictable design workflows.

Conclusions:

• A systematic approach to understanding protein assembly is essential for advancing multispecific antibody development.
• The proposed framework aims to overcome current hurdles and enable predictable design of next-generation biologics.
• Further investigation into molecular assembly will pave the way for more effective therapeutic strategies.